Vascular access for haemodialysis is key in renal patients both due to its associated
morbidity and mortality and due to its impact on quality of life. The process, from the creation …

Central vein stenosis (CVS) is commonly seen in patients receiving hemodialysis through an
arteriovenous access, threatening the usability of arteriovenous access for dialysis …

Abstract The National Kidney Foundation's Kidney Disease Outcomes Quality Initiative
(KDOQI) has provided evidence-based guidelines for hemodialysis vascular access since …

Central venous catheters for hemodialysis remain an indispensable modality of vascular
access in the United States. Despite strong recommendations by the NKF-KDOQI guidelines …

Vascular access dysfunction is one of the most important causes of morbidity and mortality in
haemodialysis patients, contributing to up to one third of hospitalisations and accounting for …

All CVWG members are listed in Table E1 (available online at www. jvir. org). No CVWG
members received compensation or commercial support for their time and effort. Some …

More than 1 in 1,000 patients in the US has end-stage renal disease, and most patients who
require renal-replacement therapy undergo hemodialysis. By the year 2020, more than …

Hemodialysis vascular access surveillance continues to be widely recommended despite
ongoing controversy as to its benefit in prolonging access patency compared with clinical …

Central vein stenosis (CVS) is a common complication of the central venous catheter (CVC)
placement. The prevalence of CVS has mostly been studied in those who present with …

The prospective recognition of stenosis affecting dialysis vascular access and its prospective
treatment is important in the management of the hemodialysis patient. Surveillance by …